HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Canada

This article was originally published in The Rose Sheet

Executive Summary

State-of-the-art distribution facility renovated with a $9 mil. investment at the company's Canadian headquarters in Pointe-Claire, Quebec. The investment, the firm's largest since it moved from Montreal, is part of Avon's previously announced global strategy to increase market share and enhance its position among the world's top global beauty companies (1"The Rose Sheet" April 5, p. 3). Avon Canada is expected to assemble 12 mil. customer orders on behalf of its 65,000 sales representatives. Installation of the new equipment will allow Avon Canada to grow its order assembly capacity to 15 mil. orders per year by mid-year in 2001. Such technological improvements will help the company "achieve our ambitious sales growth objectives and secure a leadership position...in the field of customer service"

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel